Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.30%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
1.97 Up 0.02(0.79%) 9:40AM EDT - Nasdaq Real Time Price
Prev Close:1.95
Open:N/A
Bid:1.89 x 100
Ask:1.95 x 700
1y Target Est:5.00
Beta:1.51146
Earnings Date:Nov 4 - Nov 8 (Est.)
Day's Range:1.95 - 1.97
52wk Range:1.19 - 4.42
Volume:17,038
Avg Vol (3m):469,912
Market Cap:238.57M
P/E (ttm):N/A
EPS (ttm):-0.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
IDRAUp 0.79%238.57M
PFEUp 0.19%213.24B
DVAXUp 0.77%653.68M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):294.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.44
Quarterly EPS Est (Sep-16) :-0.11
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback